| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |